MAHWAH, NJ, Dec. 20, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it has entered into an agreement with Novation allowing its more than 65,000 members and affiliates to purchase Mindray's M7 and M5 ultrasound systems.
"We are pleased to enter into this agreement with Novation and look forward to partnering with the members it serves in supplying state-of-the-art ultrasound technology," said Michael Thompson, Vice President of Ultrasound Sales, Mindray North America. "Now these members can take advantage of Mindray's upgradeable architecture, which provides a significant price-to-value ratio.
"Mindray has been widely noted for its high-quality imaging and innovation over the years. Both the M7 and M5 systems can be used in a wide array of clinical applications. In addition, each system comes with numerous choices of transducers and options. We look forward to helping Novation's members find the right solutions for every facility's specific imaging needs," Thompson added.
Novation is the health care industry's leading supply contracting company, delivering substantial savings to more than 65,000 members and affiliates of VHA Inc., UHC, and Provista, LLC. In 2010, VHA, UHC and Provista members used Novation contracts to purchase approximately $40 billion in products and services.
"This agreement reinforces Novation's commitment to securing the best market value for the members we serve," said Mike Clemens, Vice President of Capital Equipment and Diagnostic Imaging at Novation.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in majo
|SOURCE Mindray Medical International Limited|
Copyright©2010 PR Newswire.
All rights reserved